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ABSTRACT 
Constalax churna, greenish brown powder with characteristic odor and bitter salty taste was evaluated for its 
stability, as per ICH guidelines Q1A (R2) at accelerated conditions (Temperature: 40 °C ± 2, Relative Humidity : 
75% ± 5). The real time stability is estimated at temperature: 25 °C ± 2 &relative humidity 60% ± 5.The study 
sample was observed for changes in different parameters like physico-chemical, organoleptic and microbial 
load for 6 month under accelerated conditions and for real time stability study observed for one year. Real 
time stability was comparatively estimated to evaluate actual degradation rate of Constalax Churna with 
respect to accelerated conditions. Up to six months of storage at accelerated condition, no change was 
observed in organoleptic parameters like colour, odour and taste of Constalax Churna. Changes in of different 
physico-chemical parameters were taken into account to evaluate intercept and slope. Extrapolated shelf life 
of Constalax Churna was calculated with 10% degradation rate from physico-chemical parameters at 
accelerated condition 40 °C ± 2 and 75% ± 5 RH. The present evaluation supports that the Constalax Churna 
was appropriate at accelerated condition up to 6 month storage. From this accelerated stability study it could 
be extrapolated that shelf life of Constalax Churna is 25.42 months (2.11years) for climatic zone I & II 
countries. Real time stability data of Constalax Churna showed very good stability up to 2 years. 
 KEYWORDS: Constalax Churna,  Accelerated stability,  Real time Stability, Shelf life, Ayurvedic formulations. 
INTRODUCTION
 The tradition of Ayurveda in India has been well 
documented and Ayurvedic formulations are used 
effectively in health practice since long time. Ancient 
Ayurvedic literature have mentioned the importance of 
Shelf life of the Ayurvedic formulations. Not only shelf life 
but some of the authentic Ayurveda books have also 
described in detail about the factors responsible for 
degradation of the formulation and also the time period 
after which the formulation becomes unfit to use. 
Ayurvedic Formulary of India also has given the time 
period from the date of manufacture within which the 
formulations should be consumed for best results. [1] 
 Ayurvedic drugs have different constituents with 
different concentrations which make the formulation 
complex in nature. The stability, purity and quality of 
finished Ayurvedic formulation depends upon the 
complete evaluation of all constituents.  
 Stability study provides evidence on how quality 
of a drug substance or product varies with time under 
influence of variety of environmental factors such as, 
temperature, humidity and light and also to establish a 
retest period for the drug substance or product and 
recommended storage conditions. So we can say stability 
study is necessary as an assessment of product quality. [2] 
Each product has specific shelf-life based on its 
characteristics (physical and chemical) as well as 
environmental and biological factors. Accelerated stability 
study can be helpful to predict reliable shelf life of drugs. 
[2,3] Stability testing of herbal drugs is a challenging risk, 
because the entire herb or herbal product is regarded as 
the active matter, regardless of whether constituents with 
defined therapeutic activity are known. [4] 
 The purpose of a stability testing is to provide 
proof on how the quality of the herbal products varies with 
the time under the influence of environmental factors such 
as temperature, light, oxygen, moisture, other ingredient 
or excipients in the dosage form, particle size of drug, 
microbial contamination, trace metal contamination, 
leaching from the container and to establish a 
recommended storage condition and shelf-life.[5,6] 
Accelerated stability and real time stability are the two 
types of evaluations available. Real time study requires 
longer time period to conduct.  
 In routine practice of Ayurveda, powdered form 
(Churna) formulations are widely used for treatment. The 
potency of Churna forms is best up to two months as per 
the Ayurvedic pharmacology[7] after which they start 
degrading gradually thus losing their efficacy. However, it 
doesn’t lose the potency to treat the element to that stage 
that it can’t be utilized for salutary uses. The storage 
condition is one of the important aspects affecting shelf-
life of the formulation. Detailed precise guidelines about 
shelf life estimation or stability of the pure Ayurvedic 
products are not given till date in any Government 
organization except a Gazette notification issued by 
Government of India on 20th October, 2009 with slight 
modification in the earlier draft notification issued on 26th 
November, 2005.[8,9] In present research work, evaluation 
of accelerated stability study was conducted to find out the 
shelf-life of Constalax Churna. 
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 METHODOLOGY  
 CONSTALAX is an Ayurvedic multiherbal 
formulation (Churna) in powdered form. Ingredients are 
dried powders of Sonamukhi (Casia Augustifolia), Sunthi 
(Zingiber Officinale), Saunf (Foeniculum Vulgeri), 
Baalhirada (Terminalia Bellerica), Ajwain (Ptychotis 
Ajowan) and Narikellavan (Cocos Nucifera) fried with Rock 
salt) in specific proportion. All these constituents have 
been reported as effective laxative in authentic Ayurvedic 
literature. [10,11]  
 For evaluation of stability, a freshly prepared 
formulation, Constalax Churna, was considered. Constalax 
Churna was packed in airtight food grade plastic container 
having aluminum foil covering. 
Parameters of evaluation  
 As per ICH guideline Q1. A (R2)[12] evaluation of 
accelerated stability and real time stability study was 
conducted. The study sample was stored under specific 
conditions as mentioned below, 
For Accelerated stability: Temperature: 40°C ± 2, 
Relative Humidity (RH): 75 % ± 5.  
For Real time stability: Temperature: 25 °C ± 2, Relative 
Humidity (RH): 60 % ± 5.  
 The change was observed during 6 months for 
accelerated stability and 1 year for real time stability study 
at an interval of 0,1,3,6 and 12 months. Real time stability 
was comparatively carried out to evaluate the actual 
degradation rate of Constalax Churna with respect to 
accelerated condition. 10% degradation was set to 
extrapolate of the accelerated stability data at the 
acceptable point. Real time aging factor 5 and 3.3 were 
used for extrapolation of shelf life.  
 The parameters considered for evaluation of stability 
were 1. Organoleptic characters like colour, odour and 
taste, 2. Physico-chemical parameters like Loss on drying, 
pH, Total ash, Water soluble, extractive value, bitter 
residue, total saponin and total tannin.3. Microbial load.  
Assessment of Organoleptic Parameters 
The nature of the Ayurvedic formulation indicated by its 
colour while taste and odour of the formulation are very 
susceptible indicators.  
Color: Constalax Churna in quantity of 5 grams was taken 
into watch glasses. A perfectly white background was used 
and the sample was observed for colour with naked eye in 
white tube light. 
Odour: Sample of 2 gram Constalax Churna was smelled 
for odour test 
Taste: A pinchful of Constalax Churna was tasted on taste 
buds of tongue.  
Loss of drying  
 Loss on drying was determined by weighing about 
2gm of the Constalax Churna in previously weighed dried 
petridish (tarred evaporating dish) and dried in an oven at 
1050C, till two consecutive weights, which do not differ by 
more than 5mg. The weight after drying was noted and 
loss on drying was calculated. The percentage was 
expressed as % w/w with reference to air dried sample. [13] 
pH  
 For pH determination 1 g of Constalax Churna 
mixed with 100 ml distilled water in a 100 ml volumetric 
flask. The solution was sonicated for about 10 minutes. 
The pH was measured with the help of digital pH meter.  
Water soluble extractive value  
 About 5 gm accurately weighed Constalax Churna 
was macerated in a glass-stopper conical flask. 100 ml 
chloroform water was added and macerated for 6 hours,  
shaking frequently and then allowed to stand for 18 hours 
then after 24 hrs it was filtered rapidly and 20 ml of the 
filtrate was transferred in a tarred flat bottom evaporating 
dish with a pipette and evaporated to dryness on a boiling 
water bath. Then evaporating dish was dried at 105 0C for 
6 hrs and then cooled and weighed. From the weight of the 
residue the percentage of water soluble extractive was 
calculated and expressed as % w/w with reference to air 
dried sample. [13] 
Total ash  
 The ash value was determined by incinerating about 
5g of the granulation air-dried material, in a previously 
weighed crucible at gradually increasing heat up to 450 0C 
until it is carbon free. Then cooled in a desiccator and 
weighed. The percentage of total ash was calculated and 
expressed as % w/w of air dried material. [13] 
Total Tannin  
For blank preparation: In a 500 ml conical flask 300 ml 
of distilled water was taken and 25 ml of indigo sulphonic 
acid solution was added to it and mixed well. It was 
titrated against 0.02M KMnO4 solution till stable golden 
yellow color was developed. The burette reading was 
noted.  
For sample preparation: Accurately weighed about 0.05 
g of Constalax churna was taken in to a 500 ml conical flask 
and 250 ml of distilled water was added and mixed well, 
and then sonicate it for 10 min. 25 ml of the indigo 
sulphonic acid solution was added and mixed well. 
Titrated against 0.02M KMnO4 solution till stable golden 
yellow color was developed. The burette reading was 
noted. The percentage of total tannin was calculated using 
following factor. 1 ml of 0.02M KMnO4 is equivalent to 
0.00415g of tannin substance. [14] 
Bitter residue  
 One gram of accurately weighed Constalax churna 
was taken in a 150 ml conical flask and 50 ml of methanol 
was added. It was refluxed for half an hour on a water 
bath. Then it was filtered and the methanol extract was 
collected in a 250 ml beaker. The residue was extracted for 
another two cycles of extraction. Three methanol extracts 
were pooled and evaporated to obtain approximately 5 ml 
thick paste. The concentrated extract was shaken with 
three successive cycles of 25 ml hot water or till all the 
water soluble matter is extracted or dissolved. These 
water washed extracts were pooled and transferred it to a 
separating funnel. This aqueous extract was extracted with 
minimum 4 cycles of 25 ml of petroleum ether (60-80 0C). 
This extract was washed with 25 ml of ethyl acetate. Ethyl 
acetate extraction was repeated for three more cycles. The 
ethyl acetate extracts were pooled and transferred to a 
pre-weighed evaporating dish and evaporated to dryness. 
From the weight of the residue the percentage of bitter 
residue was calculated and expressed as % w/w with 
reference to air dried sample. [15]  
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Estimation of Total Saponin  
 Five grams of Constalax Churna, accurately 
weighed, taken in a conical flask and 50 ml 90%v/v 
methanol was added to it. It was mixed well and refluxed 
for half an hour. It was filtered after cooling. The residue 
washed with 90%v/v methanol till became almost 
colorless. Methanol extract was combined and evaporated 
on a water bath to obtain a thick paste like residue. The 
residue was treated with 25 ml petroleum ether (60-80 
0C). Petroleum ether layer was separated and discarded. 
The residue was treated with 25 ml chloroform. 
Chloroform layer was separated and discarded. The 
residue was treated with 25 ml ethyl acetate. Ethyl acetate 
layer was separated and discarded. Then 5 ml 90%v/v 
methanol was added in residue. It was shaken well to 
dissolve the residue completely. Then solution poured 
drop wise into a beaker containing 25 ml acetone with 
constant stirring to obtain precipitate. The flask containing 
the residue rinsed with minimum volume (about 2 ml) of 
90%v/v methanol. Transferred the organic layer and dry 
the residue to constant weight. The percentage of total 
saponin was calculated and expressed as % w/w with 
reference to air dried sample. [16]  
Microbial load 
 Microbial load was carried out as per standard 
procedure mentioned in Indian Pharmacopoeia.[17] It 
included Total bacterial count, Total Fungal Count, 
Presence of Escherichia coli, Salmonella spices, 
Pseudomonas aeruginosa and Staphylococcus aureus. Pure 
culture of Escherichia coli (NCIM: 2065; ATCC: 739), 
Salmonella Spp. (NCIM: 2257 NCTC: 6017), Pseudomonas 
aeruginosa (ATCC 9027), Staphylococcus aureus (ATCC 
6358) were obtained from National Collection of Industrial 
Microorganisms, Pune. The media used for the microbial 
limit test were of HiMedia Pvt. Ltd. 
RESULTS  
        The results of evaluation of stability study of Constalax 
Churna are shown in Tale No.1. It was analyzed on 0, 1, 3 
and 6 months at accelerated conditions [Temperature: 
40°C ± 2, Relative Humidity (RH): 75% ± 5] which was 
maintained up to 6 months. There was no change observed 
in color, odour and taste of formulation up to storage of 6 
months at accelerated condition (Table 1). 
 Loss on drying (LOD - moisture content); total ash 
(TA - total inorganic content); pH (acidity),  Total ash, 
water soluble ash (WSA ); Bitter residue, Total saponin 
and Total tannin were the selected Pharmacopoeial 
constants for the analysis.  
 Variation in Pharmacopoeial constants was found 
linear; it was found to decrease from initial to 3rd month 
and decreasing more again during 6th month. Total Ash 
and Water Soluble Extractive value showed a slight 
decrease from initial to 6th month in contrast to pH which 
tends to increase on storage. 
 The therapeutically beneficial constants like 
Water Soluble Extractive value, Total Saponin; Total 
Tannin has shown substantial decrease in percentage. 
Extrapolated results at 10 % degradation and months 
when 10 % degradation occurs was calculated using the 
reported formula by calculating the slope and intercept 
values for the above deviations.[18] Results of different 
physicochemical parameters were taken in consideration 
to evaluate intercept and slope (Table 2).   
               Results of microbial load of Constalax Churna were 
complying with Ayurvedic Pharmacopeia limits at initial 
month and up to 6 months (Table 1). The extrapolated 
shelf life of Constalax Churna was calculated with 10% 
degradation rate from physicochemical parameters at 
accelerated condition 40°C ± 2 and 75% ± 5 RH (Table 3). 
DISCUSSION 
 Constalax Churna finished formulation was green 
brownish in colour, with characteristic odor, bitter and 
salty, uniform solid powder without any tufts. The product 
did not show any considerable change in Organoleptic 
parameters in accelerated thermal or humidity conditions. 
Alteration in color usually occurs due to pH changes or 
light exposure.[19] In our study, no change in color was 
observed which correlates with an insignificant change in 
pH and confirms to criterion on the storage condition. 
Organoleptic characters of the drug were in predefined 
order, it was considered that shelf life is maintained, and 
any changes were attributed to the loss of its shelf life. [20] 
 Nevertheless, merely organoleptic parameters are 
not adequate to prove the shelf life in the present-day 
time. To assess the quality standards of herbal drugs and 
formulations other parameters are evaluated as chemical 
degradation ordinarily cannot be detected by the naked 
eye examination. Only excessive chemical degradation 
occasionally is accompanied by observable physical 
changes. In addition, some physical changes not 
necessarily related to chemical potency. Thus, commonly it 
should be assumed that a product that has undergone a 
physical change not explained in the labeling may also 
have undergone a chemical change, and such products 
should not be dispensed. [21] 
 As per the guidelines of Ministry of AYUSH, other 
food and drug regulatory agencies as well as WHO, the 
physico-chemical and microbial stability data is essential 
to decide the shelf life of formulations.  
Other Physico-chemical Parameters 
Loss on drying 
 The percentage of change of weight loss on drying 
from 0 month was 5.7%, 6.2% and 6.5% at1, 3 and 6 
months, respectively, which showed that there was no 
significant change in moisture content. Perhaps, the 
moisture content did not differ as this formulation was 
subjected to stability chamber in airtight containers, which 
were of good standard quality and prevent moisture 
adsorption. 
 The presence of excessive amount of water in 
plant drugs causes hydrolysis of constituents, other 
biochemical reactions and the growth of bacteria and 
fungi. However, the water content in plant drugs can vary 
between 8% and 14%.[22] It was assumed that the test drug 
contain very less amount of water, hence there was no 
significant physico-chemical changes and microbial 
growth. 
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Ash values 
 The percentage change of total ash, at 1, 3 and 6 
months was 14.32, 14.41%, 14.38%, respectively, in 
accelerated stability condition from initial month. As these 
changes were <5%, it confirms to the ICH guideline. [23] 
pH values 
 The pH value of 1% solution was 5.08, 5.8 and 6.1 
at 1, 3 and 6 months respectively. As these changes were 
below 5%, to be considered as insignificant as per the ICH 
guidelines. 
 The value of pH is the predominant factor 
influencing the quality of product. Many chemical and 
microbiological reactions are controlled by pH. Researcher 
found that in presence of acidic substances i.e., with low 
pH value, the bacterial count would be less while the 
chances of higher bacterial count would be more with 
neutral or higher pH.  This suggests that a neutral or 
alkaline pH favors high contamination levels of the herbal 
preparations. [24] The pH of the Constalax formulation was 
6.1 or less and microbial count was also within the normal 
limit as per WHO guidelines, similar findings were 
mentioned in previous research work. [24] 
Extractive values & presence of acidic substances 
 The change in percentage of Water soluble 
extractive value was from 49.54%, 48.12%, 47.34%, 
47.11% from initial month, at 1, 3 & 6 months respectively. 
Change in Bitter residue was from 3.89% to2.90 %.  
 Percentage change in total saponin was 1.04 % at 
0–3 months and 1.66% at 0–6 months and in total tannin 
was 0.8% from initial to 3 months and 1.2% in 0 to 6 
months. 
 All these changes in Extractive values and 
quantitative estimation of secondary metabolites were not 
more than 5%, so it confirms to ICH stability guideline. 
Microbial analysis 
 The study sample showed absence of pathogenic 
bacteria like E. coli, Salmonella, S. aureus, and P. 
aeruginosa. Thus, Constalax Formulation confirms to the 
standards set by WHO [25], API. [26] 
 In the beginning, from 0 to 3 months, slight 
increase in total count was seen. That was mostly because 
of destruction of bacteria due to the thermal conditions of 
stability chamber. Further increase in total count was on 
account of spores present.  
 However, these total bacterial count and fungal 
count were under the prescribed limits of WHO. Low pH 
and moisture content of the study sample might be 
responsible for low or controlled microbial load.  
 To confirm the shelf life/stability of product, 
change in the assay from its initial value should not vary 
more than 5% and meet the acceptance criteria such as 
appearance, physical, and chemical attributes, etc., 
However, even 90% of labeled potency is commonly 
considered as the minimum acceptable potency level. [27] 
 For evaluation of stability of Constalax Churna, the 
test drug formulation, 5% variation limit was fixed as per 
the ICH guidelines to assess the physico-chemical 
parameters. It has been proposed that 3 months at 
40°C/75% RH is roughly equivalent to 24 months at room 
temperature (25°C). [28] 
 As per the consideration, it can be affirmed that SS 
will be stable for 3.3 years at room temperature. According 
to the “Shelf life Recommendations for Supplements 
Guidelines for Manufacturers,” if a study was carried out at 
10°C temperature above the ambient temperature, an 
estimate of shelf life equals to × 2 accelerated storage time. 
[29] As the formulation was tested at 40°C temperature, 
which is 10°C above the room temperature, that is, 
30°C/70% RH (climatic zone IV-for India), and the 
accelerated storage time was 6 months. Hence, as per this 
regulation the study sample will be stable for 1-year. 
 However, the most popular concept in this regard 
is Grimm's statement. Grimm mentioned that, predictive 
factor for zone IV was 3.3 of the accelerated study period. 
It means if the product is stable for 6 months at 
40°C/75%RH, its shelf life will correspond to 20 months at 
30°CC/70% RH (climatic zone IV). [30] 
 Thus, in the view of above interpretations, it can 
be safely affirmed that Constalax Churna has the shelf life 
of 25 months at room temperature.  
Table 1: Results of different parameters of Constalax Churna at 40 °C ± 2 and 75% ± 5 RH in different intervals 
Sr. No Parameter Initial Month 1st Month 3rd Month 6th Month 
01 Colour Green Brownish Colored Complies Complies Complies 
02 Odour Characteristic Complies Complies Complies 
03 Taste Bitter & Salty Complies Complies Complies 
04 Loss on drying (% w/w) 5.1 5.7 6.2 6.5 
05 pH value (1% w/v solution) 5.06 5.08 5.8 6.1 
06 Total ash (%w/w) 14.29 14.32 14.41 14.38 
07 Water soluble extractive value (%w/w) 49.54 48.12 47.34 47.11 
08 Bitter residue (%w/w) 3.89 3.72 3.40 2.90 
09 Total saponin (%w/w) 17.26 16.88 16.22 15.66 
10 Total tannin (%w/w) 26.60 25.50 24.20 23.60 
11 Total bacterial count (CFU/g) 30×103 51×103 25×104 33×105 
12 Total yeast and mould (CFU/g) 20×101 22×101 32×102 60×103 
13 E. coli Absent Absent Absent Absent 
14 P.areuginosa Absent Absent Absent Absent 
15 S.spp Absent Absent Absent Absent 
16 S.aureus Absent Absent Absent Absent 
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Table 2: Intercept and slope of different physico-chemical parameters of Constalax Churna 
Condition: 40 °C ± 2 and 75% ± 5 RH 
Parameters Initial Month 1st Month 3rd Month 6th Month Intercept Slope 
LOD 5.1 5.7 6.2 6.5 5.33 0.21 
pH value 5.06 5.08 5.8 6.1 5.03 0.18 
Total ash 14.29 14.32 14.41 14.38 14.31 0.02 
Water soluble extractive value 49.54 48.12 47.34 47.11 48.91 0.36 
Bitter residue 3.89 3.72 3.40 2.90 3.89 0.16 
Total saponin 17.26 16.88 16.22 15.66 17.17 0.26 
Total tannin 26.60 26.2 25.8 25.4 26.48 0.19 
Table 3: Extrapolated shelf life of Constalax Churna from different physico-chemical parameters 
Condition: 40 °C ± 2 and 75% ± 5 RH 
Parameters 
 
Result at Initial 
Month 
Result at 10% 
Degradation  
Months when 10% 
degradation occurs 
LOD 5.1 4.59 0.98 
pH value 5.06 4.55 4.80 
Total ash 14.29 12.87 9.70 
Water soluble extractive value 49.54 44.58 7.52 
Bitter residue 3.89 3.50 2.42 
Total saponin 17.26 15.53 3.52 
Total tannin 26.60 23.94 6.47 
Mean Months at accelerated condition 5.04 
Extrapolated shelf life of Constalax Churna 25.42 
CONCLUSION 
 The present investigations supports that the 
Constalax Churna was appropriate and stable under 
accelerated conditions of storage up to 6 months. From the 
accelerated study this can be extrapolated that the average 
shelf life of Constalax Churna is 25.42 months (2.11 years). 
Real time stability data of Constalax Churna showed very 
good stability up to 2 year. 
LIMITATIONS 
 The main limitation of the study is absence of 
qualitative evaluation by densitometric high-performance 
thin layer chromatography (HPTLC) fingerprinting. by 
long-term and real-time studies should be carried out as 
the accelerated stability studies are not enough to 
determine drugs shelf life. 
 It is recommended that the formulation should be 
evaluated further by applying appropriate biochemical, 
immunological methods for degradation products in 
formulation so as to prevent drug-induced adverse effects. 
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